Page 1 of Clinical Trials for Surrogate marker, 307 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Prospective, Open-labeled Trial in Patients With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
Last Updated: April 27, 2012
Condition(s): Heart Failure, Congestive
2
Not yet recruiting
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
Last Updated: April 23, 2012
Condition(s): Fluid Over-load
3
Completed
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
Last Updated: April 18, 2012
Condition(s): Breast Cancer
4
Completed
Vitamins C and Vitamin E and Cardiovascular Risk
Last Updated: September 2, 2008
Condition(s): Diabetes
5
Recruiting
Syndecan-1 a Surrogate Marker for IBD
Last Updated: March 22, 2012
Condition(s): Inflammatory Bowel Diseases
6
Recruiting
Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers
Last Updated: April 14, 2011
Condition(s): Advanced Adult Hepatocellular Carcinoma
7
Completed
A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
Last Updated: September 27, 2006
Condition(s): Atherosclerosis
8
Active, not recruiting
Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)
Last Updated: August 27, 2009
Condition(s): Dengue Shock Syndrome
9
Completed
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)
Last Updated: June 23, 2005
Condition(s): HIV Infections
10
Recruiting
Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients
Last Updated: July 21, 2009
Condition(s): HIV Infection; Atherosclerosis
11
Terminated
Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
Last Updated: September 30, 2011
Condition(s): Genetic Markers; Cardiac Toxicity; Breast and Skin Motion
12
Enrolling by invitation
Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis
Last Updated: July 14, 2011
Condition(s): Multiple Sclerosis
13
Recruiting
A Proof of Concept Study to Evaluate the Additive Effects of HFA-BDP (Qvar) to Fluticasone/Salmeterol (Seretide) on Surrogate Markers of Small and Large Airway Inflammation in Refractory Asthma
Last Updated: January 26, 2009
Condition(s): Asthma
14
Active, not recruiting
Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow
Last Updated: July 3, 2011
Condition(s): Breast Cancer
15
Completed
A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties
Last Updated: October 15, 2007
Condition(s): Relapsing-Remitting Multiple Sclerosis
16
Recruiting
Fecal Calprotectin as a Marker for Macroscopic Recurrence of Crohn's Disease After Intestinal Resection
Last Updated: December 15, 2010
Condition(s): Complicated Crohn's Disease
17
Completed
Rosuvastatin in Rheumatoid Arthritis (RORA)
Last Updated: May 15, 2008
Condition(s): Rheumatoid Arthritis
18
Terminated
An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis
Last Updated: November 30, 2007
Condition(s): Relapsing-Remitting Multiple Sclerosis
19
Recruiting
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
Last Updated: March 6, 2012
Condition(s): Asthma
20
Completed
Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
Last Updated: June 22, 2011
Condition(s): Pulmonary Arterial Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Surrogate+marker

Page 1 of Clinical Trials for Surrogate marker, 307 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About